Literature DB >> 17947638

Histone acetylation at the Ifng promoter in tolerized CD4 cells is associated with increased IFN-gamma expression during subsequent immunization to the same antigen.

Meixiao Long1, Aaron M Slaiby, Shuang Wu, Adam T Hagymasi, Marianne A Mihalyo, Suman Bandyopadhyay, Anthony T Vella, Adam J Adler.   

Abstract

When naive CD4(+) Th cells encounter cognate pathogen-derived Ags they expand and develop the capacity to express the appropriate effector cytokines for neutralizing the pathogen. Central to this differentiation process are epigenetic modifications within the effector cytokine genes that allow accessibility to the transcriptional machinery. In contrast, when mature self-reactive CD4 cells encounter their cognate epitopes in the periphery they generally undergo a process of tolerization in which they become hyporesponsive/anergic to antigenic stimulation. In the current study, we used a TCR transgenic adoptive transfer system to demonstrate that in a dose-dependent manner parenchymal self-Ag programs cognate naive CD4 cells to acetylate histones bound to the promoter region of the Ifng gene (which encodes the signature Th1 effector cytokine) during peripheral tolerization. Although the Ifng gene gains transcriptional competence, these tolerized CD4 cells fail to express substantial amounts of IFN-gamma in response to antigenic stimulation apparently because a blockage in TCR-mediated signaling also develops. Nevertheless, responsiveness to antigenic stimulation is partially restored when self-Ag-tolerized CD4 cells are retransferred into mice infected with a virus expressing the same Ag. Additionally, there is preferential boosting in the ability of these CD4 cells to express IFN-gamma relative to other cytokines with expression that also becomes impaired. Taken together, these results suggest that epigenetic modification of the Ifng locus during peripheral CD4 cell tolerization might allow for preferential expression of IFN-gamma during recovery from tolerance.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17947638      PMCID: PMC2855051          DOI: 10.4049/jimmunol.179.9.5669

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  42 in total

1.  CD4 cell priming and tolerization are differentially programmed by APCs upon initial engagement.

Authors:  Amy D Higgins; Marianne A Mihalyo; Patrick W McGary; Adam J Adler
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

2.  Cutting edge: changes in histone acetylation at the IL-4 and IFN-gamma loci accompany Th1/Th2 differentiation.

Authors:  Patrick E Fields; Sean T Kim; Richard A Flavell
Journal:  J Immunol       Date:  2002-07-15       Impact factor: 5.422

Review 3.  Variegation of the immune response with dendritic cells and pathogen recognition receptors.

Authors:  Bali Pulendran
Journal:  J Immunol       Date:  2005-03-01       Impact factor: 5.422

Review 4.  The roles of IFN gamma in protection against tumor development and cancer immunoediting.

Authors:  Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Cytokine Growth Factor Rev       Date:  2002-04       Impact factor: 7.638

5.  Androgen ablation mitigates tolerance to a prostate/prostate cancer-restricted antigen.

Authors:  Charles G Drake; Amy D H Doody; Marianne A Mihalyo; Ching-Tai Huang; Erin Kelleher; Sowmya Ravi; Edward L Hipkiss; Dallas B Flies; Eugene P Kennedy; Meixiao Long; Patrick W McGary; Lee Coryell; William G Nelson; Drew M Pardoll; Adam J Adler
Journal:  Cancer Cell       Date:  2005-03       Impact factor: 31.743

6.  Role of T-bet in commitment of TH1 cells before IL-12-dependent selection.

Authors:  A C Mullen; F A High; A S Hutchins; H W Lee; A V Villarino; D M Livingston; A L Kung; N Cereb; T P Yao; S Y Yang; S L Reiner
Journal:  Science       Date:  2001-06-08       Impact factor: 47.728

Review 7.  T-cell signalling and autoimmunity: molecular mechanisms of disease.

Authors:  Pamela S Ohashi
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

8.  Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor.

Authors:  J Kirberg; A Baron; S Jakob; A Rolink; K Karjalainen; H von Boehmer
Journal:  J Exp Med       Date:  1994-07-01       Impact factor: 14.307

9.  CD4+ T cell tolerance to parenchymal self-antigens requires presentation by bone marrow-derived antigen-presenting cells.

Authors:  A J Adler; D W Marsh; G S Yochum; J L Guzzo; A Nigam; W G Nelson; D M Pardoll
Journal:  J Exp Med       Date:  1998-05-18       Impact factor: 14.307

10.  Reciprocal changes in tumor antigenicity and antigen-specific T cell function during tumor progression.

Authors:  Gang Zhou; Zhengbin Lu; John D McCadden; Hyam I Levitsky; Aimee L Marson
Journal:  J Exp Med       Date:  2004-12-13       Impact factor: 14.307

View more
  6 in total

1.  Self-antigen prevents CD8 T cell effector differentiation by CD134 and CD137 dual costimulation.

Authors:  Suman Bandyopadhyay; Meixiao Long; Harry Z Qui; Adam T Hagymasi; Aaron M Slaiby; Marianne A Mihalyo; Hector L Aguila; Robert S Mittler; Anthony T Vella; Adam J Adler
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

2.  CD8+ dendritic cell-mediated tolerance of autoreactive CD4+ T cells is deficient in NOD mice and can be corrected by blocking CD40L.

Authors:  Jeffrey D Price; Nicole M Beauchamp; Gwendoline Rahir; Yongge Zhao; Cosima C Rieger; Annie W Lau-Kilby; Kristin V Tarbell
Journal:  J Leukoc Biol       Date:  2013-09-30       Impact factor: 4.962

3.  The E3 ubiquitin ligase Cbl-b regulates expansion but not functional activity of self-reactive CD4 T cells.

Authors:  Marie-Clare St Rose; Harry Z Qui; Suman Bandyopadhyay; Marianne A Mihalyo; Adam T Hagymasi; Robert B Clark; Adam J Adler
Journal:  J Immunol       Date:  2009-10-15       Impact factor: 5.422

Review 4.  Variegated Outcomes of T Cell Activation by Dendritic Cells in the Steady State.

Authors:  Jessica Bourque; Daniel Hawiger
Journal:  J Immunol       Date:  2022-02-01       Impact factor: 5.426

5.  A Two-Step Process of Effector Programming Governs CD4+ T Cell Fate Determination Induced by Antigenic Activation in the Steady State.

Authors:  Adeleye Opejin; Alexey Surnov; Ziva Misulovin; Michelle Pherson; Cindy Gross; Courtney A Iberg; Ian Fallahee; Jessica Bourque; Dale Dorsett; Daniel Hawiger
Journal:  Cell Rep       Date:  2020-11-24       Impact factor: 9.423

Review 6.  Applications of Antibody-Based Antigen Delivery Targeted to Dendritic Cells In Vivo.

Authors:  Jessica Bourque; Daniel Hawiger
Journal:  Antibodies (Basel)       Date:  2022-01-25
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.